(Q36788871)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Norma A Bobadilla

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

11 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

F2-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429034%20AND%20SRC:MED&resulttype=core&format=json

Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Regression of existing glomerulosclerosis by inhibition of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Involvement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular matrix accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Aldosterone in the development and progression of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Role of endothelin in cyclosporine-induced glomerular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Evidence that the inhibition of Na+/K(+)-ATPase activity by FK506 involves calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Immunosuppressant-induced nephropathy: pathophysiology, incidence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Regulatory roles for small G proteins in the pancreatic beta-cell: lessons from models of impaired insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Aldosterone reduces baroreceptor discharge in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Cyclosporin increases the density of angiotensin II subtype 1 (AT1) receptors in mouse medullary thick ascending limb cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007

Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2007